These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24796611)

  • 1. Fetal fibronectin as a biomarker of preterm labor: a review of the literature and advances in its clinical use.
    Foster C; Shennan AH
    Biomark Med; 2014; 8(4):471-84. PubMed ID: 24796611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal fibronectin as a predictor of spontaneous preterm labour in asymptomatic women with a cervical cerclage.
    Duhig KE; Chandiramani M; Seed PT; Briley AL; Kenyon AP; Shennan AH
    BJOG; 2009 May; 116(6):799-803. PubMed ID: 19432568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative fetal fibronectin and cervical length in symptomatic women: results from a prospective blinded cohort study
    Levine LD; Downes KL; Romero JA; Pappas H; Elovitz MA
    J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3792-3800. PubMed ID: 29727248
    [No Abstract]   [Full Text] [Related]  

  • 4. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
    Melchor JC; Navas H; Marcos M; Iza A; De Diego M; Rando D; Melchor I; Burgos J
    Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative fetal fibronectin: who is still treating for threatened preterm labor and does it help?
    Peláez LM; Fox NS; Chasen ST
    J Perinat Med; 2008; 36(3):202-5. PubMed ID: 18576928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis.
    Melchor JC; Khalil A; Wing D; Schleussner E; Surbek D
    Ultrasound Obstet Gynecol; 2018 Oct; 52(4):442-451. PubMed ID: 29920825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the quantitative fetal fibronectin test and PAMG-1 test for the prediction of spontaneous preterm birth in patients with signs and symptoms suggestive of preterm labor.
    Ravi M; Beljorie M; El Masry K
    J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3909-3914. PubMed ID: 29807458
    [No Abstract]   [Full Text] [Related]  

  • 8. [Economical impact of preterm delivery management based on fetal fibronectin results].
    García Alonso LA; Ayala Méndez JA; Jiménez Solís G; Aguilar Gutiérrez F; Díaz Cueto L
    Ginecol Obstet Mex; 2004 Aug; 72():385-93. PubMed ID: 15526554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal fibronectin for evaluation of preterm labor in the setting of cervical cerclage.
    Benson JE; Landy HJ; Ghidini A; Drassinower D; Poggi SH
    J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2330-2. PubMed ID: 22694302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of cervicovaginal fetal fibronectin in a community hospital setting.
    Incerti M; Ghidini A; Korker V; Pezzullo JC
    Arch Gynecol Obstet; 2007 May; 275(5):347-51. PubMed ID: 17051404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined fetal fibronectin and cervical length and spontaneous preterm birth in asymptomatic triplet pregnancies.
    Fox NS; Rebarber A; Roman AS; Klauser CK; Peress D; Saltzman DH
    J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2308-11. PubMed ID: 22563765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical and biochemical screening for the risk of preterm labor.
    Wax JR; Cartin A; Pinette MG
    Clin Lab Med; 2010 Sep; 30(3):693-707. PubMed ID: 20638582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
    Shennan A; Crawshaw S; Briley A; Hawken J; Seed P; Jones G; Poston L
    BJOG; 2006 Jan; 113(1):65-74. PubMed ID: 16398774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identification the risk of preterm labor :the role of fetal fibronectin].
    Karamisheva V; Ivanov S; Nikolov A; Jordanova D; Dimitrov G; Nachev A
    Akush Ginekol (Sofiia); 2015; 54(1):3-6. PubMed ID: 25909122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement.
    Bruijn MM; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers HC; Spaanderman ME; Bloemenkamp KW; Haak MC; Bolte AC; Vandenbussche FP; Woiski MD; Bax CJ; Cornette JM; Duvekot JJ; Nij Bijvank BW; van Eyck J; Franssen MT; Sollie KM; van der Post JA; Bossuyt PM; Opmeer BC; Kok M; Mol BW; van Baaren GJ
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():220-224. PubMed ID: 27750180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of cervical length measurement and fibronectin testing in women with threatened preterm labor.
    van Baaren GJ; Vis JY; Grobman WA; Bossuyt PM; Opmeer BC; Mol BW
    Am J Obstet Gynecol; 2013 Nov; 209(5):436.e1-8. PubMed ID: 23791688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of quantitative fetal fibronectin for spontaneous preterm birth in asymptomatic pregnancies: a systematic literature review and meta-analysis.
    Ruma MS; Betts M; Dodman S; Neupane B
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2279923. PubMed ID: 37953268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the use of fetal fibronectin in an algorithm for preterm labor reduce triage evaluation times?
    Lee GT; Burwick R; Zork N; Kjos S
    J Matern Fetal Neonatal Med; 2013 May; 26(7):706-9. PubMed ID: 23170788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal fibronectin testing and pregnancy outcomes among Texas Medicaid patients at risk for preterm birth.
    Barner JC; Petrilla AA; Kang HA; Shen X; Alshehri AM; Sullivan EM; Troeger KA; Richards KM; Blackwell SC
    Am J Manag Care; 2017 Dec; 23(19 Suppl):S363-S370. PubMed ID: 29297659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of fetal fibronectin testing for women with symptoms of preterm labour in routine clinical practice within a New Zealand population.
    Groom KM; Liu E; Allenby K
    Aust N Z J Obstet Gynaecol; 2006 Oct; 46(5):440-5. PubMed ID: 16953860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.